Jørgensen F, Elsborg L
Dept. of Clinical Physiology, Central Hospital, Hillerød, Denmark.
Scand J Gastroenterol. 1991 Mar;26(3):263-8. doi: 10.3109/00365529109025040.
Sixty patients with endoscopically verified oesophagitis entered a double-blind study comparing the effect of 1 g of sucralfate granulate given four times a day and cimetidine, 400 mg twice a day. Fifty-two patients, 26 treated with cimetidine and 26 with sucralfate, were examined with short-term pH monitoring before and after 12 weeks of treatment. In about half of the patients, 19 treated with cimetidine and 11 treated with sucralfate, the oesophageal motility was studied with a radionuclide test before and after treatment. The sucralfate treatment did not affect either mean pH or the emptying rate but reduced the number of spikes. The cimetidine treatment increased mean pH and reduced the number of spikes but did not affect emptying rates. Both groups had significantly prolonged mean transit time (MTT) compared with healthy volunteers. MTT did not change after either treatment. The residual activity in the sitting position was significantly increased after cimetidine. It is concluded that the pharmacodynamic effect on oesophageal motility is different for the two drugs in question. Primary dysmotility might be involved in the pathogenesis of oesophagitis.
60例经内镜证实患有食管炎的患者进入一项双盲研究,比较每日4次服用1克硫糖铝颗粒剂与每日2次服用400毫克西咪替丁的效果。52例患者,26例接受西咪替丁治疗,26例接受硫糖铝治疗,在治疗12周前后进行短期pH监测。在大约一半的患者中,19例接受西咪替丁治疗,11例接受硫糖铝治疗,在治疗前后用放射性核素试验研究食管动力。硫糖铝治疗既不影响平均pH值也不影响排空率,但减少了尖峰次数。西咪替丁治疗增加了平均pH值并减少了尖峰次数,但不影响排空率。与健康志愿者相比,两组的平均转运时间(MTT)均显著延长。两种治疗后MTT均未改变。西咪替丁治疗后坐位时的残余活性显著增加。结论是,所讨论的两种药物对食管动力的药效学作用不同。原发性动力障碍可能参与了食管炎的发病机制。